• info@platform-residras.com

International Registry of Dravet Syndrome and other Syndromes correlated with genes on SCN1A and PCDH19

Zogenix Provides Corporate Update and Reports Third Quarter Financial Results | Zogenix, Inc The Investor Relations website contains information about Zogenix, Inc's business for stockholders, potential investors, and financial analysts.
Pubblication around Dravet Syndrome and Drug Resistant Epilepsy shared a link.
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis Background Approximately one-third of patients with epilepsy presents seizures despite adequate treatment. Hence, there is the need to search for new therapeutic options. Cannabidiol (CBD) is a major...
Pubblication around Dravet Syndrome and Drug Resistant Epilepsy shared a link.
Cannabis and epilepsy. - PubMed - NCBI https://www.ncbi.nlm.nih.gov/pubmed/30337476
Pract Neurol. 2018 Oct 18. pii: practneurol-2018-002058. doi: 10.1136/practneurol-2018-002058. [Epub ahead of print]
Altered vaccine-induced immunity in children with Dravet syndrome. - PubMed - NCBI Epilepsia. 2018 Apr;59(4):e45-e50. doi: 10.1111/epi.14038. Epub 2018 Mar 7.
Pubblication around Dravet Syndrome and Drug Resistant Epilepsy shared a link.
Sudden Unexplained Death in Epilepsy (SUDEP): Risks and Prevention Sudden Unexplained Death in Epilepsy (SUDEP) refers to the unexplained death of a seemingly healthy person with epilepsy where no cause of death can be found. What do doctors need to know about this mysterious and devastating phenomenon? Dr. Elizabeth ...
DESIREepilepsyproject.eu Participants at the final annual meeting of the DESIRE project, Florence Italy 12 -13 Sept 2018
Pubblication around Dravet Syndrome and Drug Resistant Epilepsy shared DESIREepilepsyproject.eu's post.
Malattie rare. Ne soffrono 30 milioni di europei. Le strategie di Ema per lo sviluppo... L’Agenzia europea del farmaco fa il punto sullo sviluppo di farmaci per le malattie rare. Ad oggi, nella UE sono commercializzati oltre 140 farmaci orfani che offrono nuove opzioni di trattamento per i pazienti.
Pubblication around Dravet Syndrome and Drug ...
Zogenix Announces New Data on Psychological and Socioeconomic Impact of Dravet Syndrome and Other Epileptic... The Investor Relations website contains information about Zogenix, Inc's business for stockholders, potential investors, and financial analysts.
Pubblication around Dravet Syndrome and Drug Resistant Epilepsy shared a link.
GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of... Vienna, Austria, 28 August 2018: GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the development and commercialization of cannabinoid prescription medicines, presents a variety of data on cannabidiol oral solution (CBD) at the ...
Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death Spider venom is a rich source of peptides, many targeting ion channels. We assessed a venom peptide, Hm1a, as a potential targeted therapy for Dravet syndrome, the genetic epilepsy linked to a mutation in the gene encoding the sodium channel ...
Epidiolex in Italia: farmaco CBD per epilessia - Farmagalenica Disponibilità di Epidiolex in Italia, farmaco non stupefacente con CBD cannabidiolo in farmacia, da cannabis per sindrome Lennox-Gastautsindrome o Dravet.
Pubblication around Dravet Syndrome and Drug Resistant Epilepsy shared a link.
A prospective open‐label trial of a CBD/THC cannabis oil in dravet syndrome - McCoy -... Annals of Clinical and Translational Neurology Volume 0, Issue 0 Research Article Open Access A prospective open‐label trial of a CBD/THC cannabis oil in dravet syndrome Bláthnaid McCoy Corresponding Author E-mail address:blathnaid.mccoy@sickkids.ca Division of Neurology, the Hospital for Sick Ch...
...

Load More